Judith ruined the company years ago… Her misaligned go to market strategy and Next Science’s inability to go the drug pharma route to get this approved with a code that would pay them through the pharmaceutical reimbursement pathway created this spiral to the bottom of the ocean soap opera that had been playing out the past few years. Last one to leave turn the lights out.
Judith ruined the company years ago… Her misaligned go to market...
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $62.81M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 14967 | 1 |
View Market Depth
| Last trade - 10.06am 03/10/2024 (20 minute delay) ? |
| NXS (ASX) Chart |
Day chart unavailable